Skip to main content
. Author manuscript; available in PMC: 2019 Feb 4.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Sep 3;74(5):955–967. doi: 10.1007/s00280-014-2569-7

Table 1.

Perifosine dosing schema

Day 1 loading dose (mg)
Day 2–21 maintenance dose (mg)
Cycle 1 Subsequent cycles Cycle 1 Subsequent cycles
Level 1 Level 1
 I(a) 300 × 1 dose 100  50 50
 I(b) 150 × 2 doses 100
 I(c) 100 × 3 doses 100
Level II Level II
 II(a) 600 × 1 dose 200  100 100
 II(b) 300 × 2 doses 200
 II(c) 200 × 3 doses 200
Level III Level III
 III(a) 900 × 1 dose 300  150 150
 III(b) 450 × 2 doses 300
 III(c) 300 × 3 doses 300
Level IV Level IV
 IV(a) 1,200 × 1 dose 400  200 200
 IV(b) 600 × 2 doses 400
 IV(c) 400 × 3 doses 400
Level V Level V
 V(a) 1,500 × 1 dose 1,000  250 250
 V(b) 500 × 3 doses 1,000
 V(c) 250 × 6 doses 1,000

In order to better tolerate the large number of capsules per dose (50 mg/pill), the indicated loading doses are divided in two parts and administered every 6 h on day 1